Sutro Biopharma Reports First Quarter 2024 Financial Results, Business Highlights and Select Anticipated Milestones

Go back to Sutro Biopharma Reports First Quarter 2024 Financial Results, Business Highlights and Select Anticipated Milestones
(NASDAQ: STRO) Delayed: 31.83 +0.28 (0.89%)
Previous Close $31.55    52 Week High
Open $30.67    52 Week Low
Day High $32.76    P/E N/A 
Day Low $30.00    EPS
Volume 51,023